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Abstract
Precise genome modification is essential for the molecular dissection of Candida albicans, and is yielding invaluable
information about the roles of specific gene functions in this major fungal pathogen of humans. C. albicans is naturally
diploid, unable to undergo meiosis, and utilizes a non-canonical genetic code. Hence, specialized tools have had to be
developed for gene disruption in C. albicans that permit the deletion of both target alleles, and in some cases, the recycling
of the Candida-specific selectable markers. Previously, we developed a tool based on the Cre recombinase, which recycles
markers in C. albicans with 90–100% efficiency via site-specific recombination between loxP sites. Ironically, the utility of this
system was hampered by the extreme efficiency of Cre, which prevented the construction in Escherichia coli of stable
disruption cassettes carrying a methionine-regulatable CaMET3p-cre gene flanked by loxP sites. Therefore, we have
significantly enhanced this system by engineering new Clox cassettes that carry a synthetic, intron-containing cre gene. The
Clox kit facilitates efficient transformation and marker recycling, thereby simplifying and accelerating the process of gene
disruption in C. albicans. Indeed, homozygous mutants can be generated and their markers resolved within two weeks. The
Clox kit facilitates strategies involving single marker recycling or multi-marker gene disruption. Furthermore, it includes the
dominant NAT1 marker, as well as URA3, HIS1 and ARG4 cassettes, thereby permitting the manipulation of clinical isolates as
well as genetically marked strains of C. albicans. The accelerated gene disruption strategies afforded by this new Clox system
are likely to have a profound impact on the speed with which C. albicans pathobiology can be dissected.
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Introduction
Candida albicans is a major opportunistic pathogen of humans.
Most healthy individuals carry C. albicans as a relatively harmless
commensal in the microflora of their oral cavity, gastrointestinal
and urogenital tracts. However, the fungus is a frequent cause of
mucosal infections (thrush) in otherwise healthy individuals, and in
severely immunocompromized patients C. albicans is able to
disseminate throughout the body, causing potentially fatal systemic
infections [1,2]. Therefore, major goals in the field include the
dissection of C. albicans pathobiology as well as the development of
more sensitive diagnostic tools and more effective antifungal
therapies [3].
The precise mechanistic dissection of C. albicans pathobiology
and drug resistance has depended upon the development of
molecular tools that permit the accurate disruption of target genes
in this fungus. Several aspects of C. albicans biology have slowed
progress and demanded the development of Candida-specific tools.
Specifically, C. albicans exists primarily as a diploid, and although
haploid forms can now be generated via concerted chromosome
loss [4], this fungus does not seem to undergo meiosis to complete
a standard sexual cycle [5–7]. Therefore, both alleles of a target
locus must be disrupted to generate homozygous deletion mutants
in C. albicans, and ideally, the genetic markers used to select
transformants must be recycled to permit the sequential deletion of
more than one locus [8–11]. As a result, gene disruption in
C. albicans is a relatively time-consuming process. Furthermore,
C. albicans exploits a non-canonical genetic code [12–14]. Conse-
quently, specific selectable markers that circumvent the issues
associated with usage of the CTG codon have had to be developed
for this fungus [8,13,15–19].
Existing strategies for gene disruption include the exploitation
and recycling of the URA3 marker [8,10,11]. These approaches
involve the deletion of the first allele in a C. albicans ura3/ura3 host
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by targeted integration of a URA3-based disruption cassette at the
desired locus, and the selection of transformants via uridine
prototrophy. Positive selection using 5-fluoroorotic acid (5-FOA) is
then required to recycle the URA3 marker, because the generation
of ura3- segregants, via homologous recombination between the
flanking repeats in these disruption cassettes, is relatively rare
[8,10]. 5-FOA selection for ura3- cells is commonly used in model
yeasts [20]. However, 5-FOA has been shown to cause chromo-
somal damage in C. albicans [21]. Alternative auxotrophic
transformation markers have been developed, such as HIS1,
ARG4 and LEU2 genes [15,16,18], but in most cases these cassettes
are not recyclable.
Morschhauser and colleagues [22] addressed the paucity of
recyclable marker systems by generating a FLP recombinase-
mediated C. albicans gene disruption system. In this cassette, FLP
expression is regulated by the inducible SAP2 promoter to mediate
site-specific recombination between the FRT sites that flank this
URA3 disruption cassette. The serial use of this system allows the
sequential disruption of both target alleles using the URA3 marker
[22]. This system was improved by the addition of a dominant
selection marker, SAT1, which confers nourseothricin resistance
upon C. albicans (the SAT1 flipper): [23]. Shen and co-workers [19]
then adapted this FLP-based system by replacing the SAT1 marker
with NAT1, which is a codon-optimized Streptomyces noursei NAT1
gene that also confers nourseothricin resistance. More recently,
Morschhauser’s group has described a modified SAT1 flipper,
which was designed to minimize basal FLP expression levels [24].
These recyclable FLP cassettes have proven invaluable tools for
the study of genes involved in C. albicans pathogenicity. The
efficiency of FLP-mediated recombination and marker recycling
varies, with reports of 8–40% resolution for the URA3-FLP system
[22], about 20% for SAT1-FLP [23], and more recently, resolution
frequencies of up to 100% for SAT1-FLP cassettes (Joachim
Morschhauser, personal communication).
Recently, we constructed a Cre-loxP system for gene disruption
and marker recycling in C. albicans [25]. Cre catalyses site-specific
recombination between loxP elements in P1 bacteriophage [26,27].
This molecular specificity has been exploited through the
development of Cre-loxP-based recombination tools developed
for Saccharomyces cerevisiae and mammalian cells [28,29]. Our C.
albicans system is analogous to these tools, involving the use of Cre
to recycle transformation markers via recombination between
flanking loxP sites [25]. We constructed a methionine-regulatable
MET3p-cre cassette (CAD) and three disruption cassettes with
different selectable markers: loxP-ARG4-loxP (LAL), loxP-HIS1-loxP
(LHL) and loxP-URA3-loxP (LUL). We were unable to clone
MET3p-cre into these loxP disruption cassettes because the Cre
recombinase encoded by the synthetic, codon-optimized cre gene
was exceedingly efficient, catalysing self-resolution of loxP-MET3p-
cre-loxP cassettes in E. coli. Therefore, this Cre-loxP system suffers
the disadvantage that, in comparison with other gene disruption
systems [19,23], it requires an additional transformation step to
introduce the MET3p-cre sequences into C. albicans after the two
target alleles have been disrupted [25]. However, this Cre-loxP
system enjoys the advantage of high recombination efficiencies in
C. albicans (.90% marker resolution), thereby circumventing the
need to select for resolved segregants [25] and providing the
potential to significantly accelerate the gene disruption process.
Here we describe the development of an enhanced Cre-loxP
toolkit (Clox) that exploits the advantages of the old tools while
overcoming their disadvantages. The new Clox kit facilitates rapid,
efficient and flexible gene disruption and marker recycling in C.
albicans, both for auxotrophic laboratory strains and prototrophic
clinical isolates. The construction of a new synthetic, codon-
optimized, intron-containing cre gene has allowed the inclusion of
MET3p-cre within stable, loxP-flanked, Clox cassettes that carry
URA3 or NAT1 markers (URA3-Clox and NAT1-Clox, respectively).
These URA3-Clox and NAT1-Clox cassettes support gene disruption
either via the sequential use and recycling of a single marker, or
using multiple markers. The efficiency of this Clox system permits
the accurate generation of resolved homozygous null mutants in
less than two weeks, thereby significantly reducing the time
required for gene disruption in C. albicans. Consequently, the Clox
system will accelerate functional analysis programmes and
provides a platform technology for other forms of genome
manipulation in C. albicans.
Results
The Clox kit
The utility of the original Cre-loxP system was compromized by
the inability to construct stable cassettes carrying MET3p-cre
flanked by loxP sites because there was sufficient expression of Cre
from MET3p-cre in E. coli to catalyse loxP recombination [25].
Therefore, we designed a synthetic intron-containing cre gene that
would prevent the expression of functional Cre in E. coli, whilst
permitting the expression of functional Cre in C. albicans
(Figure 1A). We selected the second intron from the C. albicans
TUB2 gene, because it is relatively short (164 nucleotides) and well
characterized [30,31]. We then introduced two point mutations
into the TUB2 intron to create two in-frame stop codons that
would prevent translational read-through of the intron in E. coli.
This modified CaTUB2 intron sequence was inserted into the 343
codon cre open reading frame such that it interrupts codon 135.
The cre open reading frame was then codon-optimized, all 18
CTG codons being replaced with preferred leucine codons during
this process [25,32]. Synonymous non-preferred codons were used
in places to remove inconvenient restrictions sites. Then a short 39-
untranslated region from C. albicans ADH1 was added, and
transcriptional termination sequences from S. cerevisiae CYC1 were
introduced, because this terminator is well-characterized [33] and
is functional in C. albicans [34]. Finally, NheI and NcoI sites were
designed at the 59- and 39-ends of the cre gene to facilitate its
cloning into the loxP-URA3-loxP disruption cassette in the plasmid
pLUL2 [25], and a 59-XmaI site inserted to facilitate the
subsequent insertion of the C. albicans MET3 promoter. The
structure of this synthetic, intron-containing, codon-optimized cre
gene is illustrated in Figure 1A, and its complete sequence is
presented in Figure S1. The cloning of this synthetic cre gene into
pLUL2, and the subsequent insertion of MET3p, generated the
plasmid pLUMCL2, which carries the URA3-Clox disruption
cassette (Figure 1B).
The URA3-Clox cassette is suitable for gene disruption in
commonly used C. albicans ura3/ura3 laboratory strains, but is not
suitable for the manipulation of prototrophic clinical isolates,
which require a dominant selectable marker. Therefore, we
replaced the URA3 sequence in pLUMCL2 with the NAT1
sequence from pJK863 [19] to create a NAT1-Clox cassette in the
plasmid pLNMCL (Figure 1B). This cassette permits dominant
selection via nourseothrycin resistance.
Previously we constructed a series of vectors to facilitate the
construction of control C. albicans strains that have the relevant
marker genes stably reintegrated into their genomes at the RPS1
locus (CIp10, CIp20, CIp30: [25]). Therefore, we constructed an
analogous plasmid for the reintegration of NAT1 at RPS1 (CIp-
NAT) (Figure S2). We chose this locus because numerous
laboratories have confirmed that the insertion of CIp plasmids at
RPS1 does not affect the phenotype or virulence of C. albicans [35].
C. albicans Clox Gene Disruption System
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The Clox Strategy – Multi-marker Disruption
The NAT1-Clox and URA3-Clox cassettes may be used alone or
in combination with existing cassettes that carry alternative
auxotrophic markers (Figure 1B). Hence the Clox cassettes are
suitable for gene disruption in C. albicans using both multi-marker
disruption and single marker recycling strategies (Figure 2).
To validate the multi-marker disruption strategy (Figure 2), we
used the LHL (loxP-HIS1-loxP) and URA3-Clox cassettes (Figure 3)
to generate a homozygous ade2/ade2 null mutation in C. albicans
RM1000 (his1- ura3-: Table 1). The first ADE2 allele was disrupted
by targeted integration of an ade2D::LHL cassette. The resultant
His+ (ADE2/ade2D::LHL) strain was then transformed with an
ade2D::URA3-Clox cassette to generate a His+ Uri+ (ade2D::LHL/
ade2::URA3-Clox) strain. At each stage, transformants were selected
on medium containing methionine and cysteine to repressMET3p-
cre expression. Before marker recycling, transformants were single-
celled on fresh medium containing methionine and cysteine to
remove untransformed background cells. MET3p-cre cassettes are
stably maintained in the C. albicans genome as long methionine
and cysteine are present to repress the MET3 promoter. Then Cre
resolves loxP-containing cassettes extremely efficiently once this
repression is released [25]. Therefore it was important to maintain
transformants in the presence of methionine and cysteine.
Selecting for URA3 and HIS1 transformants when MET3p-cre is
derepressed led to the generation of non-resolvable mutants,
essentially because this selects for C. albicans segregants that either
express non-functional Cre or carry aberrant loxP sites.
Having selected His+ Uri+ cells, and confirmed their Ade-
status, Cre-mediated recombination was induced by derepressing
MET3p-cre expression. Cells were grown for 4 h at 30uC in SC
broth lacking methionine and cysteine and supplemented with
adenine, histidine and uridine. Cells were then plated on the same
medium. As before [25], over 90% resultant colonies were
auxotrophic for uridine and histidine. Hence there was no need
to select for resolved (ura3-) segregants with 5-FOA. The loss of
HIS1 and URA3 sequences from these segregants (i.e. the
resolution of the LHL and URA3-Clox cassettes) was demonstrated
by diagnostic PCR (Figure 3B), confirming the functionality of the
intron-containing MET3p-cre gene in C. albicans. The strains
generated at each stage of the gene disruption process displayed
the expected auxotrophic requirements (Figure 3A), and their
genotypes were confirmed by diagnostic PCR (Figure 3B).
The Clox Strategy – single Marker Recycling
To validate the URA3-Clox cassette for single marker recycling
(Figure 2), we used it to disrupt GSH2 (orf19.6404), which encodes
a putative glutathione synthase in C. albicans [36]. C. albicans
RM1000 was transformed with a PCR-amplified gsh2::URA3-Clox
cassette (Tables 1 and S1). Uri+ transformants (GSH2/
gsh2D::URA3-Clox) were selected on SC lacking uridine and
containing methionine and cysteine, and then streaked on the
same medium to select single colonies. The URA3-Clox cassette
was then resolved by culturing transformants overnight in YPD
containing uridine and without supplemental methionine and
cysteine. The majority (.90%) of the resultant segregants were
Figure 1. Structure of the synthetic cre gene and Clox disruption cassettes. (A) Cartoon illustrating the components of the synthetic cre
gene including the CaMET3 promoter (MET3p: grey), the two codon-optimized cre exons (blue), the CaTUB2 intron, 39-untranslated sequence from the
CaADH1 gene (yellow), the transcriptional terminator from ScCYC1 (red), and engineered restriction sites for cloning. The DNA sequence of the
synthetic cre exons and CaTUB2 intron is provided in Figure S1. (B) The Clox kit. Cartoons illustrating the structures of the URA3-Clox and NAT1-Clox
cassettes (this study) and the LUL, LHL and LAL cassettes [25]; Black arrows, loxP sites; blue arrows, MET3p-cre transcriptional start sites; open wavey
boxes, common PCR priming sites for the disruption cassettes.
doi:10.1371/journal.pone.0100390.g001
C. albicans Clox Gene Disruption System
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Figure 2. Cartoons illustrating the exploitation of Clox cassettes for multi-marker gene disruption and single marker recycling. (see
text).
doi:10.1371/journal.pone.0100390.g002
C. albicans Clox Gene Disruption System
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Uri- (GSH2/gsh2D::loxP). The second GSH2 allele was then
disrupted by retransforming Uri- cells with the same gsh2::URA3-
Clox cassette. Uri+ transformants (gsh2D::loxP/gsh2D::URA3-Clox)
were selected on SC lacking uridine and containing methionine
and cysteine, and then streaked on the same medium to select
single colonies. Transformants were then grown in YPD contain-
ing uridine to promote URA3-Clox resolution, and then streaked on
YPD plates (without supplements) to obtain single colonies. Once
again, large numbers of Uri- segregants (gsh2D::loxP/gsh2D::loxP)
were generated, and 5-FOA selection was not required. The
strains generated at each stage of the process displayed the
expected auxotrophies and genotypes, the URA3-containing
strains growing slightly better on YPD lacking uridine (Figure 4).
Interestingly, the diagnostic PCR revealed that some
gsh2D::URA3-Clox cells had undergone Cre-mediated recombina-
tion even during growth on media containing methionine and
cysteine (Figure 4B). Therefore, under these growth conditions,
leaky MET3p-cre expression appears to be sufficient to promote
some Clox resolution. C. albicans gsh2D/gsh2D cells were sensitive to
oxidative stress (Figure 4A), which is consistent with the predicted
glutathione synthase activity of Gsh2 [36].
To confirm that the NAT1-Clox cassette can be used to
inactivate loci in prototrophic clinical isolates via single marker
recycling, we deleted the ADE2 locus in C. albicans SC5314
(Table 1). To inactivate the first ADE2 allele, cells were
transformed with an ade2::NAT1-Clox cassette, nourseothricin
resistant (NouR) transformants selected on YPD supplemented
with nourseothricin, methionine and cysteine, and these transfor-
mants restreaked onto the same medium. To resolve the NAT1-
Clox cassette, purified NouR isolates were grown overnight in YPD
Table 1. Strains used in this study.
Strain Genotype Source
SC5314 Clinical isolate [65]
RM1000 ura3D::imm434/ura3D::imm434, his1D::hisG/his1D::hisG [15]
CClox101 RM1000 plus ADE2/ade2D::LHL this study
CClox102 RM1000 plus ade2D::URA3-Clox/ade2D::LHL this study
CClox103 RM1000 plus ade2D::loxP/ade2D::loxP this study
CClox104 SC5314 plus ADE2/ade2D::Nat1-Clox this study
CClox105 SC5314 plus ADE2/ade2D::loxP this study
CClox106 SC5314 plus ade2D::Nat1-Clox/ade2D::loxP this study
CClox107 SC5314 plus ade2D::loxP/ade2D::loxP this study
CClox108 RM1000 plus GSH2/gsh2D::URA3-Clox this study
CClox109 RM1000 plus GSH2/gsh2D::loxP this study
CClox110 RM1000 plus gsh2D::URA3-Clox/gsh2D::loxP this study
CClox112 RM1000 plus gsh2D::loxP/gsh2D::loxP this study
doi:10.1371/journal.pone.0100390.t001
Figure 3. Validation of Clox cassettes for multi-marker gene disruption. The LHL and URA3-Clox cassettes were used to generate a
homozygous ade2D/ade2D mutation in C. albicans RM1000. (A) Confirmation of the expected auxotrophic requirements for wild type (ADE2/ADE2),
heterozygous (ade2D::LHL/ADE2), unresolved homozygous (ade2D::LHL/ade2D::URA3-Clox) and resolved homozygous mutants (ade2D::loxP/
ade2D::loxP). Growth media are specified on the right: w/o, without a specific supplement. (B) PCR confirmation of the genotypes for these
mutants using primers specific for each allele (specified on the left of each panel). PCR product lengths are given on the right of each panel. ACT1 was
used as a positive control, and a no-DNA control was included (Control).
doi:10.1371/journal.pone.0100390.g003
C. albicans Clox Gene Disruption System
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without supplements, and then streaked on YPD plates (without
supplements) to obtain single colonies. NouS segregants were
selected (ADE2/ade2::loxP), and the second ADE2 allele was then
disrupted with the same ade2::NAT1-Clox cassette. NouR transfor-
mants were selected on YPD containing nourseothricin, adenine,
methionine and cysteine, and then single-celled on the same
growth medium. To stimulate NAT1-Clox resolution, Ade- colonies
were then grown overnight on YPDA lacking methionine and
cysteine. Over 90% of the resultant segregants were NouS
(ade2::loxP/ade2::loxP). Once again, the strains generated at each
stage displayed the expected auxotrophies and genotypes
(Figures 5A and 5B). We observed leaky resolution of the NAT1-
Clox cassette in C. albicans cells grown in the presence of
methionine and cysteine, which was similar to the situation for
URA3-Clox (Figure 4B). These observations confirm the high
efficiency of marker recycling with the synthetic intron containing
cre gene.
Discussion
The accurate manipulation of specific chromosomal loci is
critical for the molecular dissection of microbial development,
pathogenicity and drug resistance. Therefore a range of elegant
tools have been developed for gene disruption in C. albicans
[8,10,15,16,18,19,22,23,25,37]. Despite the availability of these
tools, gene deletion in C. albicans remains a relatively time-
consuming process because this fungus is an obligate diploid,
apparently unable to undergo meiosis [5–7]. Consequently,
despite the valiant attempts of a number of groups [18,38–43]
we lack a comprehensive collection of homozygous C. albicans
deletion mutants that is freely available to the academic
community. Exciting recent developments suggest that a collection
of haploid null mutants could be generated [4,37], but as things
stand C. albicans haploids display fitness defects and are unstable
[4,37]. Enhanced gene disruption tools would significantly
increase the feasibility of generating a collection of deletion
mutants, whether in haploids or diploids. The Clox toolkit (Figure 1)
offers this enhancement by improving the efficiency with which
selectable markers can be recycled, increasing the yields of desired
mutants, reducing the number of requisite steps to generate these
mutants, and significantly decreasing the time required to generate
these mutants.
The recycling of selectable markers in C. albicans is desirable
for two main reasons. Firstly, a narrow range of auxotrophic
markers are available for laboratory strains (URA3, HIS1, ARG4,
LEU2) [8,15,16,18], and few dominant antibiotic markers can
be used in prototrophic clinical strains (MPAR, SAT1/NAT1,
HygB: [19,23,44–47]). Therefore, the opportunities to dissect
multigene families would be severely constrained without
marker recycling. Secondly, marker position effects can influ-
ence virulence-related phenotypes in C. albicans [48–51], and
therefore markers are generally reintegrated at a standard locus
to control for these effects [35,52,53]. Initially, marker recycling
in C. albicans was achieved via homologous recombination
between relatively large direct repeats that flank the URA3
marker gene [8,10]. However, these ura3- segregants arise
infrequently, and therefore their isolation depends on positive 5-
FOA selection, which is mutagenic [21]. The FLP-system
displays markedly improved frequencies of marker recycling that
are reported to yield 8–20% of marker-resolved segregants
[22,23], but which can approach 100% resolution (Joachim
Morschhauser, personal communication). No selection of NouS
segregants is required, but these smaller colonies must be
carefully distinguished from larger NouR background colonies
[23]. Cre-loxP also offers extremely high frequencies of marker
resolution that can approach 100% in C. albicans [25]. However,
the utility of the initial system was prejudiced by the inability to
clone stable cre-containing loxP-flanked disruption cassettes in E.
coli [25]. The construction of an intron-containing cre gene has
successfully circumvented this problem (Figure 1). The leaky
resolution of Clox cassettes even in C. albicans cells grown on
methionine and cysteine, which is a consequence of the extreme
efficiency of this system, represents a potential drawback
(Figure 4B). Those researchers that need to retain unresolved
versions of their mutants might utilise our earlier Cre-loxP
system [25], or the current SAT1 flipper [24], which retains the
original Candida-adapted FLP, a recombinase with lower activity
than the mutated ecaFLP gene [54]. However, for most
Figure 4. Validation of URA3-Clox for single marker recycling. URA3-Clox was used to generate a homozygous gsh2D/gsh2D mutation in C.
albicans RM1000 via single marker recycling (Figure 2). (A) Confirmation of the expected phenotypes for wild type (GSH2/GSH2), unresolved
heterozygous (GSH2/gsh2D::URA3-Clox), resolved heterozygous (GSH2/gsh2D::loxP), unresolved homozygous (gsh2D::loxP/gsh2D::URA3-Clox) and
resolved homozygous mutants (gsh2D::loxP/gsh2D::loxP). Growth media are specified on the right: w/o, without a specific supplement; *, it was not
possible to test the oxidative stress sensitivity of the unresolved GSH2/gsh2D::URA3-Clox and gsh2D::loxP/gsh2D::URA3-Clox strains because
methionine and cysteine interfere with the oxidizing agent, t-BOOH. (B) PCR confirmation of the genotypes for these mutants using primers specific
for each allele (specified on the left). PCR product lengths are given on the right. ACT1 was used as a positive control, and a no-DNA control was
included (Control).
doi:10.1371/journal.pone.0100390.g004
C. albicans Clox Gene Disruption System
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researchers the high Cre efficiency is not an issue, because the
desired endpoint is generally the resolved mutant. Furthermore,
CIp10, CIp20, CIp30 and CIp-NAT facilitate stable reintegra-
tion of the desired markers into resolved mutants [25] (Figure
S2).
We have validated the exploitation of Clox cassettes for single
marker recycling and multi-marker disruption (Figure 2). Single
marker recycling demands two cycles of transformation and
marker recycling. Given the high yield of correctly resolved Clox
mutants (.90%) following MET3p-cre induction ([25]; this study),
we find that selections for resolved segregants are not required,
and that PCR diagnosis can be left till the end of the disruption
process (Figure S3). Therefore, having established the methodol-
ogy, we proceed directly to the second round of disruption without
waiting for PCR confirmation of heterozygous mutant genotypes
(retrospective genotyping). The analysis of several segregants from
several transformants is generally sufficient to yield the desired
homozygous null mutants. As a result we are now able to routinely
generate independent, resolved, homozygous null mutants in
laboratory strains and clinical isolates within two weeks. The
process is even more rapid for the multi-marker disruption strategy
which requires only one round of Cre-mediated marker resolution
(Figure 2). The notable exception is where inactivation of the
target gene confers a significant fitness defect, which necessitates
the construction of a conditional mutant [55–58]. In principle,
one-step gene deletion in haploid C. albicans strains should be even
faster, although current protocols, which include the cloning of
disruption cassettes and flow cytometry to exclude autodiploidized
segregants, takes nearly four weeks [37].
The Clox cassettes have been tested by other users. Several
general points can be made based on their successful construction
of over 50 C. albicans mutants with Clox cassettes (Figure 1). First,
off-target integration with Clox cassettes does not appear to be a
major issue. Off-target integration was rare for those mutants
whose genotypes were confirmed by Southern blotting. Also,
almost without exception, independently generated mutants have
displayed identical or very similar phenotypes. Second, the re-
disruption of the first allele is often observed during the second
round of disruption when the same PCR primers were used to
generate the second disruption cassette, and when it was not
possible to impose a double selection (e.g. for LUL and LHL
cassettes: Figure 2). However, the desired homozygous null mutant
was usually obtained after screening about 20 second round
transformants. Furthermore, this issue is circumvented by ampli-
fying the second disruption cassette with primers that target the
region deleted from the first allele. Indeed, this approach was
successful for all 11 non-essential C. albicans loci where this strategy
was employed. Third, the Clox system does not provide a magical
solution to the problems associated with deleting essential loci.
Attempts to delete both alleles of 3 C. albicans loci that appear to be
essential using Clox cassettes were unsuccessful. As observed for
other systems [10,15], triploid segregants containing a wild type
allele were obtained, rather than the desired homozygous null
mutant. We conclude that success rates with Clox appear similar to
other disruption systems.
These Clox trials confirmed a fourth point. Retrospective
genotyping of Clox mutants is practical for loci without an
anticipated phenotype. For the 14 C. albicans mutants where this
approach was tested, no problems were experienced with
retrospective genotyping. Independent homozygous null mutants
were successfully generated for 11 of the 14 target loci. For these
11 mutants, 3 independent homozygous mutants were obtained by
retrospective screening of 10 second round transformants from
each of 5 first round transformants. Regarding the other 3 loci,
their apparent essentiality was revealed more quickly by
retrospective genotyping. We conclude that the high efficiency of
Clox marker recycling makes retrospective PCR diagnosis of
C. albicans Clox mutants a feasible option.
We note that the utility of the Clox system extends beyond rapid
and convenient gene deletion. As for other cassettes [59,60], the
Clox system could be adapted to construct fluorescent protein
fusions or epitope-tag proteins in laboratory strains or clinical
isolates. In principle, Clox could also be exploited to engineer large
chromosomal deletions [61], or the induction of genetic alterations
that allow the analysis of spatial and temporal patterns of gene
expression and their role in development [62]. Therefore, the Clox
Figure 5. Validation of NAT1-Clox for single marker recycling in a prototrophic clinical isolate. NAT1-Clox was used to generate a
homozygous ade2D/ade2D mutation in C. albicans SC5134. (A) Confirmation of the expected phenotypes for wild type (ADE2/ADE2), unresolved
heterozygous (ADE2/ade2D::NAT1-Clox), resolved heterozygous (ADE2/ade2D::loxP), unresolved homozygous (ade2D::loxP/ade2D::NAT1-Clox) and
resolved homozygous mutants (ade2D::loxP/ade2D::loxP). Growth media are specified on the right: w/o, without a specific supplement; nou,
nourseothricin. (B) PCR confirmation of the genotypes for these mutants using primers specific for each allele (specified on the left). PCR product
lengths are specified on the right. ACT1 was used as a positive control, and a no-DNA control was included (Control).
doi:10.1371/journal.pone.0100390.g005
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system represents a significant step forward in the development of
the C. albicans molecular toolbox that should empower local and
genome-wide analyses of this major opportunistic pathogen of
humans.
Materials and Methods
Strains and Growth Conditions
C. albicans strains used in this study are listed in Table 1. Unless
otherwise specified, all strains were grown in YPD [63]. In some
cases strains were grown on YPDG (YPD containing 40 mg/ml
glutathione) or YPDA (YPD containing 0.01% adenine). SD
medium supplemented with auxotrophic requirements or SC
medium lacking the appropriate supplement [60] were used to
screen C. albicans cells transformed with Clox disruption cassettes.
During all selections for Clox transformants, and for all phenotyp-
ing assays, media were supplemented with 2.5 mM methionine
and 2.5 mM cysteine to repress theMET3 promoter and minimize
Cre-loxP mediated recombination. Nourseothricin resistant (NouR)
transformants were selected using 200 mg/mL nourseothricin
(Werner Bioagents, Jena, Germany). For phenotyping assays,
strains were grown overnight at 30uC, 200 rpm in SC medium
containing the appropriate supplements plus 2.5 mM methionine
and 2.5 mM cysteine. These cells were diluted in sterile water, and
104 cells were spotted onto agar plates, which were then incubated
at 30uC for two days before imaging.
Clox Construction
A synthetic, codon-optimized cre open reading frame, inter-
rupted by a C. albicans TUB2 intron at codon 135, was designed in
silico (Results), constructed by DNA2.0 (Menlo Park, CA, USA)
and cloned between the NheI and NcoI sites in pLUL2 [25] to
generate pLUCL2. The CaMET3 promoter region (1336 bp) was
then PCR-amplified using Infusion cloning primers Clox-MET3p-
F and Clox-MET3p-R (Table S1) and cloned between the NheI
and XmaI sites in pLUCL2 in front of the cre gene using an In-
Fusion HD cloning kit according to the manufacturer’s instruc-
tions (Clontech, California, USA) to generate the URA3-Clox
cassette in the plasmid pLUMCL2. The URA3 marker in
pLUMCL2 was then replaced with the NAT1 marker to generate
the NAT1-Clox cassette in the plasmid pLNMCL. NAT1 was
amplified from pJK863 [64] using the primers Clox-NAT1-F and
Clox-NAT1-R (Table S1), and then cloned between the Bpu10I
and NheI sites of pLUMCL2 by In-Fusion cloning to create
pLNMCL. The sequences of the URA3-Clox and NAT1-Clox
cassettes were confirmed experimentally. The structures of all Clox
cassettes are illustrated in Figure 1, and their sequences are
available in GenBank:
N URA3-Clox (loxP-URA3-MET3p-cre-loxP): GenBank accession
number KC999858
N NAT1-Clox (loxP-NAT1-MET3p-cre-loxP): GenBank accession
number KC999859
N LAL (loxP-ARG4-loxP): GenBank accession number DQ015897
N LHL (loxP-HIS1-loxP): GenBank accession number DQ015898
N LUL (loxP-URA3-loxP): GenBank accession number
DQ015899
CIp-NAT
CIp-NAT is a Candida albicans integrating plasmid (CIp) based
on pJK863 [19], a kind gift from Julia Kohler. pJK863 carries a
FLP-recyclable, codon-optimized NAT1 gene. To create CIp-
NAT, the RPS1 targeting sequence, including the StuI linearization
sites, was amplified from CIp10 [52] using the primers RPS1-
NAT1-F and RPS1-NAT1-R (Table S1). The resulting PCR
product was cloned between the SacII and SacI sites in pJK863,
thereby generating CIp-NAT (Figure S2). The plasmid was
sequenced from m13F to m13R and the data were deposited in
GenBank under accession number KJ174065.
Gene Disruption Using URA-Clox and NAT-Clox
The URA3-Clox and NAT1-Clox cassettes were PCR-amplified
using Extensor master mix (Thermo scientific; MA, USA) with
chimeric primers, the 59-ends of which represented short (90–
100 bp) flanking regions of homology to the target locus [59], and
the 39-ends of which hybridized to the PCR priming sites common
to all Clox cassettes (Table S1). The resulting PCR products were
used to transform C. albicans [64]. Transformants were selected on
nourseothricin-containing or uridine-lacking medium that also
contained 2.5 mM methionine and 2.5 mM cysteine to repress
MET3p-cre expression and inhibit marker resolution. Fresh Nou
R
and Uri+ transformants were single-celled on fresh medium
containing 2.5 mM methionine and 2.5 mM cysteine, and if
necessary, their genotypes confirmed by diagnostic PCR with the
primers described in Table S1.
Cre-mediated Marker Resolution
After streaking for single colonies, C. albicans transformants were
grown overnight in 10 ml SC medium that contained 2.5 mM
methionine and 2.5 mM cysteine (to repressMET3p-cre expression)
and maintained marker selection (i.e. lacked uridine or contained
nourseothricin). Cells were harvested by centrifugation, washed
twice in sterile H2O, and resuspended in 10 ml SC that lacked
methionine and cysteine (to induce MET3p-cre expression) and
without marker selection (i.e. lacked nourseothricin or contained
uridine, and if necessary, contained any supplement required to
support the new gene knock-out). Cells were incubated in this
medium at 30uC for 4 h, and then streaked onto plates containing
the same growth medium. The genotypes of the resolved mutants
were then confirmed by diagnostic PCR using the primers
described in Table S1.
Oxidative Stress Resistance
The oxidative stress resistance of C. albicans control and gsh2/
gsh2 strains was tested by growing the strains overnight at 30uC,
200 rpm in SC medium containing the appropriate supplements,
plating 104 cells on YPD containing 1 mM tert-butylhydoper-
oxide (tBOOH), and incubating the plates at 30uC for two
days.
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